Nutriband adds two directors and provides development update

Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) announced the addition of two new directors and provided updates on its AVERSA™ fentanyl patch development during its annual shareholder meeting held Jan. 24 in Orlando, Florida.

The company appointed Alessandro Puddu, an Italian chartered accountant with over 10 years of audit and corporate advisory experience, and Viorica Carlig, a senior executive with a decade of leadership experience across multinational organizations, to its board of directors.

Nutriband reported several developments for its AVERSA™ fentanyl product in 2025, including strengthening its collaboration with Kindeva through an exclusive development partnership, completing commercial manufacturing process scale-up, and obtaining patent protection in Macao. The company also held a Type C meeting with the FDA regarding chemistry, manufacturing, and controls plans.

For 2026, Nutriband plans to file a nonprovisional patent application that could extend patent protection to 2046, manufacture clinical supplies for human abuse liability trials, file an investigational new drug application with the FDA, and initiate clinical studies.

The company disclosed that the full purchase price for the proposed sale of its Pocono subsidiary to EarthVision Bio has not been received. Nutriband has collected $30,000 in weekly penalty payments of $10,000 to extend the closing date.

Nutriband filed a complaint with the Financial Industry Regulatory Authority regarding suspected naked short selling on behalf of shareholders.

The company reminded shareholders that 910,904 warrants issued during its NASDAQ uplisting on Oct. 1, 2021, will expire Oct. 1, 2026, with a strike price of $6.43, totaling $5.86 million if exercised.

Nutriband develops transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating AVERSA™ technology designed to prevent drug abuse, misuse, and accidental exposure.

You May Also Be Interested In

• Mesoblast draws $50M from five-year facility to retire existing debt
• Oracle adds 10 companies to its defense technology ecosystem
• Teledyne MEMS expands Edmonton facility with CA$620K grant